Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.10
Delayed Data
As of Feb 12
 +0.18 / +6.16%
Today’s Change
2.65
Today|||52-Week Range
6.76
-22.69%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +238.71% increase from the last price of 3.10.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$0.00
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.70%
 
 
 
 
 
 
Growthannually -884.84%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -99.90%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.